Carlos A. Zarate
Experimental Therapeutics & Pathophysiology Branch
Division of Intramural Research Programs
National Institute of Mental Health
National Institutes of Health
USA
Name/email consistency: high
- Glutamatergic modulators: the future of treating mood disorders? Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., Salvadore, G. Harv. Rev. Psychiatry (2010)
- Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. Zarate, C.A., Manji, H.K. CNS. Drugs (2009)
- Riluzole in psychiatry: a systematic review of the literature. Zarate, C.A., Manji, H.K. Expert. Opin. Drug. Metab. Toxicol (2008)
- The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Zarate, C.A., Manji, H.K. Exp. Neurol. (2008)
- Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Zarate, C.A., Singh, J.B., Carlson, P.J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D.A., Manji, H.K. Bipolar. Disord (2007)
- A double-blind, placebo-controlled study of memantine in the treatment of major depression. Zarate, C.A., Singh, J.B., Quiroz, J.A., De Jesus, G., Denicoff, K.K., Luckenbaugh, D.A., Manji, H.K., Charney, D.S. Am. J. Psychiatry (2006)
- Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Zarate, C.A., Singh, J., Manji, H.K. Biol. Psychiatry (2006)
- A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Zarate, C.A., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Arch. Gen. Psychiatry (2006)
- An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Zarate, C.A., Quiroz, J.A., Singh, J.B., Denicoff, K.D., De Jesus, G., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Biol. Psychiatry (2005)